Skip to main content
OpenTrials

Clinical trial condition

Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency

Explore clinical trials studying Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency trial results

Completed

A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

NCT01886378

Conditions
Carnitine Palmitoyltransferase (CPT II) Deficiency, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, +3 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Southern Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions